Announcement

Collapse
No announcement yet.

J Med Virol . Remdesivir for the treatment of COVID-19 in pregnancy

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    J Med Virol . Remdesivir for the treatment of COVID-19 in pregnancy


    J Med Virol


    . 2021 Mar 31.
    doi: 10.1002/jmv.26986. Online ahead of print.
    Remdesivir for the treatment of COVID-19 in pregnancy


    Dr Temi Lampejo 1



    Affiliations

    Abstract

    The devastating coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared by the World Health Organisation (WHO) in March 2020 and now at over 9 months since its declaration it continues to claim vast numbers of lives all over the world. There is no evidence that pregnant women are more susceptible to SARS-CoV-2 infection than the general population, however, pregnancy-associated immunological changes could potentially render pregnant individuals more vulnerable to severe COVID-19. This article is protected by copyright. All rights reserved.

    Keywords: COVID-19; SARS-CoV-2; coronavirus; pregnant; remdesivir.

    Tags: None
Previous template Next
Working...
X